Clinical Trials Directory

Trials / Sponsors / Seikagaku Corporation

Seikagaku Corporation

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
Dry Eye Disease
Phase 32022-07-28
CompletedPK and Safety of SI-722 in IC/BPS
Interstitial Cystitis, Bladder Pain Syndrome
Phase 1 / Phase 22020-03-30
CompletedSI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)
Lumbar Disc Herniation
Phase 32018-11-07
CompletedSI-613 Study for Knee Osteoarthritis
Osteoarthritis, Knee
Phase 22017-10-19
CompletedA Study of SI-6603 in Patients With Lumbar Disc Herniation
Intervertebral Disc Disease, Lumbar Disc Disease
Phase 32015-03-01
CompletedA Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
Dry Eye Syndromes
Phase 2 / Phase 32014-07-01
CompletedA Study of SI-6603 in Patients With Lumbar Disc Herniation
Intervertebral Disc Disease, Lumbar Disc Disease
Phase 32013-09-01
CompletedGel-One Treatment in Knee Osteoarthritis
Osteoarthritis Knee
N/A2013-08-01
CompletedA Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
Dry Eye Syndromes
Phase 22012-03-01
CompletedSI-6603 Versus Placebo in Patients With Lumbar Disc Herniation
Lumbar Vertebra Hernia
Phase 2 / Phase 32008-01-01
CompletedClinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation
Lumbar Vertebra Hernia
Phase 22007-12-01
CompletedGel-200 Extension and Open-Label Study in Osteoarthritis of the Knee
Osteoarthritis of the Knee
Phase 32007-03-01
CompletedGel-200 Versus Placebo in Osteoarthritis of the Knee
Osteoarthritis of the Knee
Phase 32006-09-01